AI Visibility Scorecard
Smarter Drug Discovery
massaffinity.com · Technology
Borderline visible. AI bots can crawl Smarter Drug Discovery, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 1 times
Claude
#1,805,383 of 2,704,685 in Technology for AI visibility
4
AEO Visibility
iBorderline · 4.1/10
25
Muse Index Score
iAI agent readiness
Basic · 25/100
8
AI Adoption
iBasic · 8/100
About Smarter Drug Discovery
from our crawl and measurement
Smarter Drug Discovery describes itself simply: "Accelerate early-stage drug discovery with Mass Affinity’s platform, targeting undruggable and complex proteins faster and more accurately." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 4.1 out of 10.
Our crawl found structured data on the page (WebSite, Organization) and a readable heading structure. It is missing an llms.txt file and a sitemap.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Good
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.1/10, Smarter Drug Discovery is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
Why MassAffinity?
Built for complexity. Designed for speed.We have built a platform that meets the reality of today’s discovery challenges. SmarterWorks in native biological contextreliableLower false positive ratesAdaptableCompatible with multiple target classesScalableFrom characterisation to screeningBuilt for todayReady for AI-driven discovery
Is this your brand?
The exact fixes for Smarter Drug Discovery
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Smarter Drug Discovery.
Source & Attribution
Scored by Engagemii on August 5, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/massaffinity
Cite this score: Engagemii (2026). "AEO Score for Smarter Drug Discovery." Retrieved from https://engagemii.com/aeo/brands/massaffinity
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform